NeuroKaire
New Jersey, United States · Biotechnology, Health Care, Medical
NeuroKaire is developing personalized medicine solutions to optimize treatment for psychiatric and neurological diseases. The company's proprietary technology assists physicians in identifying the best treatment for their patients by utilizing unique neurological biomarkers. This approach aims to improve drug therapy selection, leading to faster treatment with fewer side effects. Additionally, Neu
Key facts
- Headquarters
- New Jersey, United States
- Employees
- 39
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- www.neurokaire.com
- Company page
Recent activity at NeuroKaire
Leadership
- Talia Cohen Solal, Leading a Fast Growing Startup
- Orit Goldman, Leading Multidisciplinary R&D Projects
- Issar Yazbin, Product and Project Management Executive
- David Pattison, CPA
- Stephanie Jefferson, Director of Sales
Verified email and direct lines for NeuroKaire’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
NeuroKaire in the news
- Israeli startup NeuroKaire launches world’s first blood test to personalize depression treatment - CTech (Sep 09, 2025)
- Israeli Startup Develops Blood Test To Personalize Antidepressant Treatment - i24NEWS (Feb 08, 2026)
- NeuroKaire Secures $10 Million to Advance Precision Medicine for Mental Health - PR Newswire (Dec 17, 2024)
Companies similar to NeuroKaire
- Specialised Therapeutics · Biotechnology, Health Care, Medical, Therapeutics
- Grey Wolf Therapeutics · Biotechnology, Health Care, Medical, Therapeutics
- Nanoscope Therapeutics · Biotechnology, Health Care, Medical, Therapeutics
- Aptose Biosciences · Biotechnology, Health Care, Medical, Therapeutics
- Ascidian Therapeutics · Biotechnology, Health Care, Medical, Therapeutics
About NeuroKaire: questions and answers
What does NeuroKaire do?
NeuroKaire is developing personalized medicine solutions to optimize treatment for psychiatric and neurological diseases. The company's proprietary technology assists physicians in identifying the best treatment for their patients by utilizing unique neurological biomarkers. This approach aims to improve drug therapy selection, leading to faster treatment with fewer side effects. Additionally, Neu
Where is NeuroKaire headquartered?
NeuroKaire is headquartered in New Jersey, United States.
How many employees does NeuroKaire have?
NeuroKaire has about 39 employees.
What is the latest news on NeuroKaire?
On Nov 21, 2024, NeuroKaire Achieves CLIA Certification for its Pharmacogenetic Assay in Psychiatry and Neurology.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy